SPECIAL NOTICE
65 -- PET MRI Radiopharmaceuticals - Notice of Intent to Sole Source
- Notice Date
- 8/27/2025 11:09:38 AM
- Notice Type
- Special Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- 250-NETWORK CONTRACT OFFICE 10 (36C250) DAYTON OH 45428 USA
- ZIP Code
- 45428
- Solicitation Number
- 36C25025Q0891
- Response Due
- 9/2/2025 2:00:00 PM
- Archive Date
- 11/01/2025
- Point of Contact
- Jeffrey Rozema, Contracting Officer, Phone: 269-966-5600 x36450
- E-Mail Address
-
jeffrey.rozema@va.gov
(jeffrey.rozema@va.gov)
- Awardee
- null
- Description
- INTENT TO SOLE SOURCE The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees. The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2025, through September 30, 2026. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients. Product Name UoM Est. Annual Quantity Cu-64 Dotatate (Detectnet) 3-5 mCi Dose 25 F18 PSMA (Pylarify) 8-10 mCi Dose 70 F18 Fluorodeoxyglucose (FDG) 8-10 mCi Dose 908 F18 Neuraceq 8-10 mCi Dose 52 It is the Government s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25025Q0852 was published on Contract Opportunities from August 18, 2025 through August 22, 2025. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine. This notice satisfies the requirement at FAR 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested persons may identify their interests and capability to respond to this requirement no later than 5:00 PM Eastern Time, Tuesday, September 2, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government. Interest/capability statements shall be submitted to Jeffrey Rozema, Contracting Officer, via e-mail at jeffrey.rozema@va.gov. Telephone inquiries will not be accepted.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/a9cba37c42674b368cb8396aa987159c/view)
- Record
- SN07568384-F 20250829/250827230044 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |